Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort
Published inAtherosclerosis, vol. 284, p. 253-259
Publication date2019
Abstract
Affiliation entities
Funding
- Swiss National Science Foundation - 148522
- Swiss National Science Foundation - Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management
- Swiss National Science Foundation - Inflammation and acute coronary syndrome (ACS) - novel strategies for prevention and clinical management [140336]
Citation (ISO format)
GENCER, Baris et al. Clinical, behavioral and biomarker predictors of PCSK9 levels in HIV-infected patients naïve of statin therapy: A cross-sectional analysis from the Swiss HIV cohort. In: Atherosclerosis, 2019, vol. 284, p. 253–259. doi: 10.1016/j.atherosclerosis.2019.02.015
Main files (1)
Article (Published version)
Identifiers
- PID : unige:121602
- DOI : 10.1016/j.atherosclerosis.2019.02.015
- PMID : 30827714
Journal ISSN0021-9150